This research focuses on creating a novel rapid diagnostic test for Zika Virus NS1 protein using nanoribbon microfluidics.
Triple-negative breast cancer (TNBC) does not respond to receptor targeted treatments because they do not possess the ligands to bind to these receptors. Thus, more research needs to be explored in terms of the translational modifications that genes undergo during this disease.
Lumos can allow patients to quickly screen for glaucoma and detect the disease in its early stages. All the patient needs is a smartphone, and the app will identify the glaucoma risk rapidly and automatically.
RNA-based viruses and bacteria have been sources of large-scale epidemics and pandemics, most notably Ebola, SARS, influenza, hepatitis C, HIV, and the Zika Virus. Normal detection of these biological agents requires multiple lab processes. This project aims to develop a fully integrated lab-on-a-chip device to accomplish this.
The purpose of the project is to determine the effects of catalysts on the depolymerization of chitin using ionic liquids.
Send this to a friend